نتائج البحث - Tuomas Mirtti

تنقيح النتائج
  1. 1
    PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveillance

    PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveil... حسب Utku Lokman, Andrew Erickson, Hanna Vasarainen, Antti Rannikko, Tuomas Mirtti

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Self-supervised learning enables unbiased patient characterization from multiplexed microscopy images

    Self-supervised learning enables unbiased patient characterization from multiplexed microscopy images حسب Gantugs Atarsaikhan, Isabel Mogollón, Katja Välimäki, Tuomas Mirtti, Teijo Pellinen, Lassi Paavolainen

    منشور في 2025
    احصل على النص الكامل
    Pré-impressão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer

    Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer حسب Minna M. Boström, Heikki Irjala, Tuomas Mirtti, Pekka Taimen, Tommi Kauko, Annika Ålgars, Sirpa Jalkanen, Peter J. Boström

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer

    High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer حسب Paula Vainio, John‐Patrick Mpindi, Pekka Kohonen, Vidal Fey, Tuomas Mirtti, Kalle Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Rac1 Nucleocytoplasmic Shuttling Drives Nuclear Shape Changes and Tumor Invasion

    Rac1 Nucleocytoplasmic Shuttling Drives Nuclear Shape Changes and Tumor Invasion حسب Inmaculada Navarro‐Lérida, Teijo Pellinen, Susana A. Sánchez, Marta C. Guadamillas, Yinhai Wang, Tuomas Mirtti, Enrique Calvo, Miguel Á. del Pozo

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    <i>FZD4</i> as a Mediator of <i>ERG</i> Oncogene–Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells

    <i>FZD4</i> as a Mediator of <i>ERG</i> Oncogene–Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells حسب Santosh Gupta, Kristiina Iljin, Henri Sara, John Patrick Mpindi, Tuomas Mirtti, Paula Vainio, Juha Rantala, Kalle Alanen, Matthias Nees, Olli Kallioniemi

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    T and NK cell abundance defines two distinct subgroups of renal cell carcinoma

    T and NK cell abundance defines two distinct subgroups of renal cell carcinoma حسب Moon Hee Lee, Petrus Järvinen, Harry Nísen, Oscar Brück, Mette Ilander, Ilona Uski, Jason Theodoropoulos, Matti Kankainen, Tuomas Mirtti, Satu Mustjoki, Anna Kreutzman

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins

    Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins حسب Paula Vainio, Laura Lehtinen, Tuomas Mirtti, Mika Hilvo, Tuulikki Seppänen‐Laakso, Johannes Virtanen, Anna Sankila, Stig Nordling, Johan Lundin, Antti Rannikko, Matej Orešič, Olli Kallioniemi, Kristiina Iljin

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy

    Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy حسب Kanerva Lahdensuo, Andrew Erickson, Irena Saarinen, Heikki Seikkula, Johan Lundin, Mikael Lundin, Stig Nordling, Anna Bützow, Hanna Vasarainen, Peter J. Boström, Pekka Taimen, Antti Rannikko, Tuomas Mirtti

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Stat3 Promotes Metastatic Progression of Prostate Cancer

    Stat3 Promotes Metastatic Progression of Prostate Cancer حسب Junaid Abdulghani, Lei Gu, Ayush Dagvadorj, Jacqueline Lutz, Benjamin E. Leiby, Gloria Bonuccelli, Michael P. Lisanti, Tobias Zellweger, Kalle Alanen, Tuomas Mirtti, Tapio Visakorpi, Lukas Bubendorf, Marja T. Nevalainen

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo

    Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo حسب Sonja Lindfors, Zydrune Polianskyte-Prause, Rim Bouslama, Eero Lehtonen, Miia Mannerla, Harry Nísen, Jukka Tienari, Hanne Salmenkari, Richard A. Forsgård, Tuomas Mirtti, Markku Lehto, Per‐Henrik Groop, Sanna Lehtonen

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Autocrine Prolactin Promotes Prostate Cancer Cell Growth via Janus Kinase-2-Signal Transducer and Activator of Transcription-5a/b Signaling Pathway

    Autocrine Prolactin Promotes Prostate Cancer Cell Growth via Janus Kinase-2-Signal Transducer and Activator of Transcription-5a/b Signaling Pathway حسب Ayush Dagvadorj, Sean P. Collins, J Jomain, Junaid Abdulghani, James G. Karras, Tobias Zellweger, Hongzhen Li, Martti Nurmi, Kalle Alanen, Tuomas Mirtti, Tapio Visakorpi, Lukas Bubendorf, Vincent Goffin, Marja T. Nevalainen

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion

    Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion حسب Mari Björkman, Päivi Östling, Ville Härmä, Johannes Virtanen, J-P Mpindi, Juha Rantala, Tuomas Mirtti, Tiina Vesterinen, Johan Lundin, Anna Sankila, Antti Rannikko, Elisa Kaivanto, Pekka Kohonen, Olli Kallioniemi, Matthias Nees

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer

    Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer حسب Paula Vainio, Santosh Gupta, Kirsi Ketola, Tuomas Mirtti, John-Patrick Mpindi, Pekka Kohonen, Vidal Fey, Merja Perälä, Frank Smit, Gerald W. Verhaegh, Jack A. Schalken, Kalle Alanen, Olli Kallioniemi, Kristiina Iljin

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes

    Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes حسب Maija Puhka, Maarit Takatalo, Maria-Elisa Nordberg, Sami Valkonen, Jatin Nandania, Maria Aatonen, Marjo Yliperttula, Saara Laitinen, Vidya Velagapudi, Tuomas Mirtti, Olli Kallioniemi, Antti Rannikko, Pia Siljander, Taija M. af Hällström

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer

    Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer حسب Biswajyoti Sahu, Marko Laakso, Kristian Ovaska, Tuomas Mirtti, Johan Lundin, Antti Rannikko, Anna Sankila, Juha-Pekka Turunen, Mikael Lundin, Juho Konsti, Tiina Vesterinen, Stig Nordling, Olli Kallioniemi, Sampsa Hautaniemi, Olli A. Jänne

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    The roles of proteases in prostate cancer

    The roles of proteases in prostate cancer حسب Hannu Koistinen, Ruusu‐Maaria Kovanen, Morley D. Hollenberg, Antoine Dufour, Evette S. Radisky, Ulf‐Håkan Stenman, Jyotsna Batra, Judith A. Clements, John D. Hooper, Eleftherios P. Diamandis, Oliver Schilling, Antti Rannikko, Tuomas Mirtti

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo

    Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo حسب Lei Gu, Paraskevi Vogiatzi, Martin Puhr, Ayush Dagvadorj, Jacqueline Lutz, Amy Ryder, Sankar Addya, Paolo Fortina, Carlton R. Cooper, Benjamin E. Leiby, Abhijit Dasgupta, Terry Hyslop, Lukas Bubendorf, Kalle Alanen, Tuomas Mirtti, Marja T. Nevalainen

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity

    Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity حسب Zydrune Polianskyte-Prause, Tuomas Tolvanen, Sonja Lindfors, Vincent Dumont, Mervi Van, Hong Wang, Surjya Narayan Dash, Mika Erik Anthon Berg, Jette-Britt Naams, Laura Hautala, Harry Nísen, Tuomas Mirtti, Per‐Henrik Groop, Kristiina Wähälä, Jukka Tienari, Sanna Lehtonen

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer

    Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer حسب Khalid Saeed, Vesa Rahkama, Samuli Eldfors, D. A. Bychkov, John Patrick Mpindi, Bhagwan Yadav, Lassi Paavolainen, Tero Aittokallio, Caroline A. Heckman, Krister Wennerberg, Donna M. Peehl, Péter Horváth, Tuomas Mirtti, Antti Rannikko, Olli Kallioniemi, Päivi Östling, Taija M. af Hällström

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: